top of page

Where Al-enabled clinical evidence
stands with regulators 
and HTA bodies

A two-day scientific workshop on what is already accepted, and on what is still missing.

24–25 February 2027

Pullman Brussels Centre Midi

PROGRAMME AT A GLANCE

DAY 1, MORNING

AI-enabled evidence in regulatory and HTA practice today

DAY 1, AFTERNOON

Methods in the making

Data and biostatistics as the foundation

DAY 2, MORNING

DAY 2, AFTERNOON

The generative turn and the regulatory response

CLOSING SESSION: The unmet needs: what no method answers yet

Speakers include Flora Musuamba, Cécile Ollivier, Tina Morrisson, Stéphanie Allassonnière, Denis Umuhire, Marine Le Morvan, Stanley Durrleman, Marc Buyse, Olaf Klungel, Federico Mattiello, Devanarayan, Viswanath, Wim Goettsch, Piet Van der Graaf, Bill Malcolm, Billy Amzal, Andrea Manfrin, Frederic Cogny, and Peter Krusche. Call for abstracts open until 8 January 2027.

In association with 

cropped-Design-sans-titre10.webp

Sponsor

Design sans titre.jpg

Dear friends and colleagues,

 

It is my great pleasure, on behalf of our Scientific Committee, to welcome you to the second edition of the European Workshop on AI for Clinical Applications (EURAICA 2027), which will take place at the Pullman Hotel in Brussels, Belgium, on 24-25 February 2027.

 

Our inaugural edition explored how Artificial Intelligence can support clinical research before, during and after clinical trials. This year, we change perspective. Rather than following the chronology of clinical development, EURAICA 2027 will take stock of where we actually stand: which AI-enabled methods are already being used to generate evidence for regulatory and HTA decision making, which concrete needs they address, and with what degree of maturity and acceptance. Just as importantly, we will examine what is not yet being done - the unmet needs of sponsors, regulators and HTA bodies that current methods do not yet answer, and the scientific, methodological and operational gaps that stand in the way.

​

None of this is possible without data. A dedicated part of the program will therefore address the quality, accessibility and governance of the data required to train, validate and deploy these models, as well as the key initiatives currently shaping the European data landscape.

 

Once again, we are proud to bring together leading voices from clinical research, biostatistics, AI technologies, regulatory science and health technology assessment, to deliver insights that are both visionary and practical. This workshop is a unique opportunity to engage with academic researchers, regulatory authorities, HTA representatives, investors, entrepreneurs, and executive leaders from pharmaceutical and biotech companies involved in clinical development, medical affairs, and regulatory strategy.

 

We also invite you to join us as a Sponsor or Exhibitor, and benefit from exceptional visibility and access to a forward-looking, cross-sector audience.

 

We look forward to welcoming you to Brussels for EURAICA 2027 - and to shaping the future of clinical evidence generation together.

 

Sincerely,​

Alexandre Templier

Founder & Chair, EURAICA

Scientific Committee

Euraica 2027  (5).png

Billy Amzal

Program intelligence, modeling and AI for Global Health, Gates Foundation

Jean-Pierre Boissel

Scientific Advisor, Nova in Silico, France

Euraica speakers - post linkedin.png

Marc Buyse

Founder and Chief Scientific Officer, IDDI, Belgium

Baldur Magnusson

Flora Musuamba

Cécile Ollivier

Head Late Development Statistics & Statistical Innovation, Biometrics & Data Sciences, UCB, Basel, Switzerland

Scientific Advice Working Party EMA, Belgium

Vice-President, Global Affairs, Critical Path Institute (C-Path), Netherlands

Andrew Thomson

Owner and lead consultant, Regnitio

Venue

Pullman Brussels Centre Midi Place Victor Horta 1 1060 Brussels Belgium

February 24-25, 2027

  • LinkedIn

Contact

Thank you for sending it!

bottom of page